Spirometry at Dr. Essa Lab

Spirometry at Dr. Essa Lab

Spirometry is the foundational and most widely utilized pulmonary function test (PFT) designed to assess the physiological mechanics of the respiratory system. This non-invasive diagnostic examination measures the volume of air an individual can inhale or exhale as a function of time, alongside the speed of airflow during forced expiration. By capturing these critical metrics, spirometry provides invaluable clinical insights into the mechanical properties of the respiratory system, including airway patency, lung compliance, and the functional integrity of the respiratory musculature. At Dr. Essa Lab, we utilize advanced, high-precision spirometers equipped with state-of-the-art flow sensors to ensure the highest degree of diagnostic accuracy and clinical reproducibility for patients across Karachi and beyond.

The clinical importance of spirometry cannot be overstated. It serves as the gold standard for diagnosing, staging, and monitoring chronic obstructive pulmonary disease (COPD) and asthma. Additionally, it plays a pivotal role in differentiating between obstructive ventilatory defects, characterized by limited airflow, and restrictive ventilatory defects, characterized by reduced lung volumes. Through the generation of detailed flow-volume loops and volume-time curves, spirometry allows consultant pulmonologists and physicians to visualize the precise nature of a patient's respiratory impairment. Whether utilized for evaluating chronic respiratory symptoms, assessing pre-operative risk, or screening for occupational lung diseases, spirometry at Dr. Essa Lab delivers the precise quantitative data necessary to guide therapeutic interventions and optimize patient outcomes.

Clinical Procedure: What to Expect

Patient Preparation

To ensure highly accurate and reproducible results, patients must adhere to specific preparation guidelines prior to undergoing spirometry at Dr. Essa Lab. These steps minimize external variables that could artificially alter lung volumes or airflow dynamics:

• Bronchodilator Withholding: Patients must temporarily discontinue the use of bronchodilator medications before the test, as these drugs can mask underlying airway obstruction. Short-acting bronchodilators (such as salbutamol or albuterol) should be withheld for at least 4 to 6 hours. Long-acting beta-agonists (such as salmeterol or formoterol) and long-acting muscarinic antagonists (such as tiotropium) should be withheld for 12 to 24 hours, or as specifically instructed by the referring physician.
• Avoid Smoking: Smoking, including electronic cigarettes, must be avoided for at least 24 hours prior to the test, as nicotine and combustion products can cause acute airway irritation and bronchoconstriction.
• Dietary Restrictions: Patients should avoid consuming large, heavy meals for at least 2 hours before the procedure. A distended stomach can restrict the downward movement of the diaphragm, artificially reducing measured lung volumes.
• Avoid Caffeine: Beverages containing caffeine (such as coffee, tea, energy drinks, and certain sodas) should be avoided on the day of the test, as caffeine has mild bronchodilatory properties.
• Clothing: Patients should wear loose-fitting, comfortable clothing that does not restrict chest wall expansion or abdominal movement.
• Avoid Vigorous Exercise: Strenuous physical activity should be avoided for at least 1 to 2 hours prior to testing to ensure the respiratory system is in a resting state.
• Alcohol Consumption: Alcohol should not be consumed for at least 4 hours before the test, as it can impair coordination and the ability to perform the forced expiratory maneuvers.

During the Procedure

The spirometry procedure requires active patient participation and coordination. Upon arriving at the Dr. Essa Lab diagnostic facility, the patient will be guided through the following steps by a highly trained pulmonary technician:

• Patient Positioning: The patient is seated comfortably in an upright position in a chair with armrests. This posture is maintained throughout the test to ensure optimal chest expansion and safety in the rare event of lightheadedness.
• Application of Nose Clip: A soft, comfortable nose clip is placed on the patient's nose to prevent any air from escaping through the nasal passages, ensuring that all inhaled and exhaled air passes exclusively through the spirometer.
• Mouthpiece Seal: The patient is instructed to place their mouth around the sterile, single-use mouthpiece of the spirometer, forming a tight, airtight seal with their lips to prevent any air leakage during the maneuvers.
• The Breathing Maneuver: The technician will instruct the patient to breathe normally, then take a rapid, maximal inspiration to fill the lungs completely to Total Lung Capacity (TLC). Immediately following this full inhalation, the patient must blast the air out into the mouthpiece as hard, fast, and completely as possible, continuing to blow until their lungs are entirely empty. This expiratory effort must be sustained for a minimum of 6 seconds (or 3 seconds in children) to ensure complete emptying of the lungs.
• Repetition and Reproducibility: Because accuracy depends on maximum effort, the maneuver is repeated at least three times, and up to eight times, to obtain consistent, reproducible curves that meet international diagnostic standards (ATS/ERS guidelines).
• Bronchodilator Reversibility Testing: If indicated by the referring physician or initial findings, a bronchodilator reversibility test is performed. After the baseline spirometry, the patient inhales a standardized dose of a short-acting bronchodilator (typically salbutamol). After a waiting period of 15 minutes, the spirometry test is repeated to determine if the airway obstruction is reversible.
• Duration and Safety: The entire procedure typically takes 15 to 30 minutes. Patients may experience mild lightheadedness, dizziness, or transient coughing during the forced exhalation, which are normal and resolve quickly with brief rest periods between maneuvers.

When is a Spirometry Performed?

Diagnosing Asthma and COPD

Spirometry is the primary diagnostic tool utilized by physicians to identify obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). Chronic inflammation in these conditions leads to airway narrowing, which manifests as a reduced rate of airflow during forced expiration. Spirometry helps differentiate between the variable, reversible airway obstruction characteristic of asthma and the progressive, largely irreversible airflow limitation characteristic of COPD. This differentiation is critical for establishing an accurate diagnosis and initiating the appropriate pharmacological therapy.

Investigating Unexplained Respiratory Symptoms

Physicians frequently request spirometry when a patient presents with persistent, unexplained respiratory symptoms. These symptoms include chronic cough, wheezing, unexplained shortness of breath (dyspnea) during exertion or rest, chest tightness, and increased sputum production. By evaluating the mechanical function of the lungs, spirometry helps determine whether these symptoms originate from an underlying pulmonary pathology, helping to rule out or confirm airway hyperresponsiveness, parenchymal lung disease, or chest wall abnormalities.

Monitoring Chronic Lung Diseases

For patients already diagnosed with chronic respiratory conditions, spirometry is performed at regular intervals to monitor disease progression and evaluate the efficacy of therapeutic interventions. By comparing current spirometry parameters (such as FEV1 and FVC) with baseline measurements, clinicians can assess whether a patient's lung function is stable, deteriorating, or improving in response to medications like inhaled corticosteroids, bronchodilators, or systemic therapies. This objective data is essential for adjusting medication dosages and managing long-term treatment plans.

Pre-Operative Pulmonary Evaluation

Prior to major cardiothoracic, upper abdominal, or general surgeries, a pre-operative spirometry evaluation is often conducted to assess the patient's baseline lung function and estimate the risk of post-operative pulmonary complications. Surgery and general anesthesia can significantly impact respiratory mechanics, diaphragmatic function, and cough clearance. Spirometry helps identify patients with undiagnosed lung disease or severe impairment, allowing the surgical and anesthesia teams to implement pre-emptive respiratory therapies and customized post-operative care plans.

Occupational Health Screening

Spirometry is an essential component of occupational health surveillance programs for individuals working in environments with high exposure to airborne hazards. Workers exposed to industrial dusts, chemical fumes, silica, asbestos, coal dust, or organic sensitizers undergo routine spirometry to screen for early signs of occupational lung diseases, such as occupational asthma, pneumoconiosis, or hypersensitivity pneumonitis. Early detection of declining lung function allows for timely workplace modifications, protective measures, or relocation to prevent irreversible lung damage.

What Does a Spirometry Detect?

Spirometry is highly sensitive in detecting a wide range of physiological abnormalities, clinical parameters, and specific respiratory conditions. The test provides quantitative data that can identify:

• Forced Vital Capacity (FVC) Reduction: A decrease in the total volume of air exhaled forcefully, indicating potential restrictive lung disease or severe air trapping.
• Forced Expiratory Volume in 1 Second (FEV1) Decline: A reduction in the volume of air exhaled in the first second of the forced maneuver, a hallmark of airway obstruction.
• Reduced FEV1/FVC Ratio: The primary diagnostic index for obstructive ventilatory defects, typically defined as a ratio below 70% or below the Lower Limit of Normal (LLN).
• Obstructive Ventilatory Defect: Characterized by a disproportionate reduction in airflow relative to lung volume, commonly seen in asthma, COPD, and bronchiectasis.
• Restrictive Ventilatory Pattern: Suggested by a proportionate reduction in both FEV1 and FVC with a normal or elevated FEV1/FVC ratio, indicating potential interstitial lung disease or chest wall restriction.
• Bronchodilator Reversibility: An improvement in FEV1 or FVC by more than 12% and 200 mL after bronchodilator inhalation, strongly suggesting asthma.
• Fixed Airway Obstruction: Airflow limitation that does not significantly improve after bronchodilator administration, characteristic of established COPD.
• Peak Expiratory Flow (PEF) Reduction: A decrease in the maximum speed of expiration, reflecting large airway patency and patient effort.
• Forced Expiratory Flow (FEF 25-75%) Impairment: Reduced airflow during the middle portion of the forced expiration, often reflecting early disease in the small airways.
• Asthma Severity Staging: Categorization of asthma control and severity based on FEV1 percentage predicted.
• COPD Severity Staging (GOLD Criteria): Classification of airflow limitation severity into mild, moderate, severe, or very severe based on post-bronchodilator FEV1.
• Emphysema: Indirect physiological evidence of lung tissue destruction causing air trapping and hyperinflation.
• Chronic Bronchitis: Airway obstruction associated with chronic mucus hypersecretion and bronchial inflammation.
• Bronchiectasis: Airflow limitation resulting from permanent dilation and destruction of the large bronchi.
• Interstitial Lung Disease (ILD) Suspicion: Early physiological signs of pulmonary fibrosis or sarcoidosis characterized by restrictive patterns.
• Neuromuscular Weakness: Reduced FVC and respiratory muscle strength caused by conditions like amyotrophic lateral sclerosis (ALS), myasthenia gravis, or Guillain-Barré syndrome.
• Kyphoscoliosis Impact: Restrictive lung impairment due to severe chest wall deformities limiting lung expansion.
• Vocal Cord Dysfunction (VCD): Flattening of the inspiratory or expiratory portion of the flow-volume loop, indicating upper airway obstruction.
• Tracheal Stenosis: Fixed upper airway obstruction characterized by symmetrical flattening of both inspiratory and expiratory loops.
• Poor Patient Effort: Suboptimal, non-reproducible curves that indicate the need for coaching or point to physical limitations in performing the test.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. Spirometry tests performed at our fully equipped diagnostic centers are processed with high efficiency. The raw data and flow-volume curves generated during the test are immediately reviewed and interpreted by our consultant pulmonologists or qualified clinical specialists. The finalized, comprehensive spirometry report—complete with numerical values, percentage predicted calculations, flow-volume loops, and clinical interpretations—is typically available within a few hours of the test completion.

Patients can easily access their diagnostic reports through Dr. Essa Lab's secure online patient portal. By visiting our official website or utilizing our dedicated mobile application, patients can view, download, and share their spirometry reports directly with their referring physicians. Physical copies of the reports can also be collected from the respective testing branch. Our extensive network of branches across Karachi ensures that high-quality pulmonary diagnostics and seamless report delivery are always within reach for our patients.

Spirometry Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Forced Vital Capacity (FVC)	≥ 80% of the predicted value based on age, sex, height, and ethnicity.	< 80% of predicted, suggesting restrictive lung disease or severe air trapping.
Forced Expiratory Volume (FEV1)	≥ 80% of the predicted value.	< 80% of predicted, indicating airway obstruction or severe restriction.
FEV1/FVC Ratio	≥ 70% (or above the Lower Limit of Normal, LLN).	< 70% (or below LLN), indicating an obstructive ventilatory defect (e.g., asthma, COPD).
Peak Expiratory Flow (PEF)	Consistent with predicted values; sharp, rapid expiratory peak on the loop.	Reduced peak flow, indicating large airway obstruction or poor expiratory effort.
Bronchodilator Reversibility	Minimal change (< 12% and < 200 mL improvement in FEV1 or FVC).	Significant improvement (≥ 12% and ≥ 200 mL), indicating reversible airway disease (asthma).
Flow-Volume Loop Shape	Symmetrical, rapid rise to peak expiratory flow followed by a linear decline to zero.	Scooping of the expiratory curve (obstruction) or a miniature, narrow loop (restriction).
Forced Expiratory Flow (FEF 25-75%)	≥ 60% to 79% of predicted value.	Reduced values, suggesting early small airway disease or mild obstruction.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Spirometry?

• Experienced Healthcare Professionals: Our pulmonary function tests are conducted by highly trained, certified technicians under the clinical supervision of expert pulmonologists.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication, ensuring that patients are thoroughly guided through the breathing maneuvers.
• Quality Diagnostic Services: Dr. Essa Lab is a pioneer in diagnostic services in Pakistan, maintaining strict quality control and adherence to international testing standards.
• Professional Reporting: Every spirometry report undergoes rigorous clinical review to provide accurate, detailed, and actionable diagnostic interpretations.
• Modern Diagnostic Approach: We utilize state-of-the-art spirometers equipped with advanced calibration and flow-sensing technology for maximum precision.
• Comfortable Environment: Our diagnostic centers are designed to provide a clean, hygienic, and stress-free environment for all patients.
• Convenient Location: With an extensive network of branches across Karachi and other major cities, accessing high-quality diagnostic services is highly convenient.
• Commitment to Accurate Diagnosis: Since 1987, Dr. Essa Lab has remained dedicated to delivering trustworthy, evidence-based diagnostic results to support patient health.